Efficacy and safety of gemcitabine and capecitabine combination for patients with previously treated advanced primary pulmonary lymphoepithelioma-like carcinoma: a retrospective single-arm cohort study

BACKGROUND: Primary pulmonary lymphoepithelioma-like carcinoma (PLELC) is a rare and unique subtype of non-small cell lung cancer (NSCLC). Studies reporting on salvage treatment for pretreated PLELC are limited. Positive interactions between gemcitabine (GEM) and capecitabine (CAP) have been demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Qi-Hua, Liu, Hui, Huang, Cai-Wen, Kang, Li-Ping, Qiu, Bo, Mai, Jian-Liang, Lin, Yong-Bin, Liang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903090/
https://www.ncbi.nlm.nih.gov/pubmed/36762055
http://dx.doi.org/10.21037/tlcr-22-256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903090/
https://www.ncbi.nlm.nih.gov/pubmed/36762055
http://dx.doi.org/10.21037/tlcr-22-256

Ejemplares similares